Related Experiment Video

Updated: Aug 16, 2026

Analysis of Simian Immunodeficiency Virus-specific CD8+ T-cells in Rhesus Macaques by Peptide-MHC-I Tetramer Staining
06:25

Analysis of Simian Immunodeficiency Virus-specific CD8+ T-cells in Rhesus Macaques by Peptide-MHC-I Tetramer Staining

Published on: December 23, 2016

The simian immunodeficiency virus transmembrane protein is poorly immunogenic in inactivated virus vaccine

M P Cranage1, B W McBride, E W Rud

  • 1Centre for Applied Microbiology and Research, Porton Down, Salisbury, UK.

Vaccine
|July 1, 1995
PubMed

Insights

Antibody responses to simian immunodeficiency virus (SIV) transmembrane proteins (TMP) were studied in macaques. Infected macaques recognized multiple TMP regions, while SIV vaccine recipients showed weak responses, suggesting reduced immunogenicity in vaccines.

Area of Science:

  • Immunology
  • Virology
  • Vaccine Development

Background:

  • Transmembrane proteins (TMP) of immunodeficiency lentiviruses are key targets for AIDS vaccine design.
  • The SIV-macaque model is crucial for evaluating vaccine candidates and understanding immune responses.
  • Investigating antibody recognition of SIV TMP is vital for improving vaccine efficacy.

Purpose of the Study:

  • To investigate antibody responses to linear determinants within the SIVmac TMP.
  • To compare immune recognition of TMP in SIV-infected versus SIV-vaccinated macaques.

Main Methods:

  • Rhesus macaques were infected with SIVmac or vaccinated with inactivated SIVmac.
  • Antibody responses were assessed against a series of overlapping 20-mer peptides representing SIVmac TMP.

Main Results:

  • Infected macaques recognized multiple linear epitopes in both external and internal TMP domains.
  • SIV vaccine recipients exhibited highly restricted and weak antibody responses to TMP.
  • Formalin inactivation of SIVmac significantly diminished the immunogenicity of TMP.

Conclusions:

  • The immunogenicity of SIV transmembrane proteins is selectively lost during vaccine preparation.
  • Current SIV vaccine strategies may fail to elicit robust antibody responses against critical TMP epitopes.
  • Further research is needed to enhance TMP immunogenicity in future AIDS vaccine designs.

More Related Videos

Single-cell Quantitation of mRNA and Surface Protein Expression in Simian Immunodeficiency Virus-infected CD4+ T Cells Isolated from Rhesus macaques13:13

Single-cell Quantitation of mRNA and Surface Protein Expression in Simian Immunodeficiency Virus-infected CD4+ T Cells Isolated from Rhesus macaques

Published on: September 25, 2018

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses10:13

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Published on: May 6, 2019

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...